Showing 2 posts of 2 posts found.

Lilly posts promising P3 Taltz data

February 14, 2018
Research and Development Cosentyx, Eli Lilly, IL-17, Novartis, Taltz, biotech, drugs, pharma, pharmaceutical

The IL-17 market is a crowded space, and one dominated by Novartis’ Cosentyx. Eli Lilly is attempting to challenge that, …


NICE green-light for Novartis skin drug

May 29, 2015
Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab

NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …

Latest content